Back to search

Article

Lymphoid Enhancer-Binding Factor 1 (LEF1) immunostaining as a surrogate of β-catenin (<i>CTNNB1)</i>mutations

2022-04-02

Abstract excerpt

<h4>Background</h4> Activating mutations affecting exon 3 of the β-catenin ( CTNNB1 ) gene result in constitutive activation of WNT signaling and are a diagnostic hallmark of several tumor entities including desmoid-type fibromatosis. They also define clinically relevant tumor subtypes within certain entities such as endometrioid carcinoma. In diagnostics, β-catenin immunohistochemistry is widely used as a surroga...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5717ece9-b755-5265-a40b-84c32448b926
DOI
10.1101/2022.03.30.22273113
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lymphoid Enhancer-Binding Factor 1 (LEF1) immunostaining as a surrogate of β-catenin (<i>CTNNB1)</i>mutationsDOI 10.1101/2022.03.30.22273113
Select a neighboring publication to make it the new centre.